When PO representatives were asked about the desired improvement of cancer care in the survey, side-effect management and quality of life related aspects were the most frequently mentioned categories (see Table 4). More efficient use of biomarkers to determine the adequate treatment was also underlined to achieve the appropriate treatment for the right patient at the right time, leading to better disease control and longer survival.